Cargando…

Incidence of Olfactory Dysfunction in Patients with COVID-19 in a Tertiary Hospital in Saudi Arabia

BACKGROUND: Coronavirus disease (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2, a novel virus that emerged in China in December 2019. In many cases of COVID-19, olfactory dysfunction (OD) is the only symptom. OBJECTIVES: This study aimed to examine the incidence of OD in...

Descripción completa

Detalles Bibliográficos
Autores principales: Alfallaj, Rayan, AlSkait, Ghada, Alamari, Nouf, Alfawzan, Lama, Abualgasem, Mohammed, Alotaibi, Naif H., Sumaily, Ibrahim, Alarifi, Ibrahim, Alsaleh, Saad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703475/
https://www.ncbi.nlm.nih.gov/pubmed/36452479
http://dx.doi.org/10.1177/21526575221140809
_version_ 1784839857082728448
author Alfallaj, Rayan
AlSkait, Ghada
Alamari, Nouf
Alfawzan, Lama
Abualgasem, Mohammed
Alotaibi, Naif H.
Sumaily, Ibrahim
Alarifi, Ibrahim
Alsaleh, Saad
author_facet Alfallaj, Rayan
AlSkait, Ghada
Alamari, Nouf
Alfawzan, Lama
Abualgasem, Mohammed
Alotaibi, Naif H.
Sumaily, Ibrahim
Alarifi, Ibrahim
Alsaleh, Saad
author_sort Alfallaj, Rayan
collection PubMed
description BACKGROUND: Coronavirus disease (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2, a novel virus that emerged in China in December 2019. In many cases of COVID-19, olfactory dysfunction (OD) is the only symptom. OBJECTIVES: This study aimed to examine the incidence of OD in patients with COVID-19 and identify an association between OD and COVID-19-related morbidity and admission. DESIGN: This was a cross-sectional study. METHODS: Real-time reverse transcription polymerase chain reaction-confirmed cases of COVID-19 from the Security Forces Hospital electronic registry from June 2020 to September 2020 were included in our study. Data on medical background, severity of the disease, and other related factors were collected through phone calls and electronic healthcare systems and analyzed to investigate OD in the participants. RESULTS: Of the participants, 68% had OD, with a mean recovery time of 18 days and a mean follow-up time of 129 days (76-211 days). OD was negatively correlated with admission and morbidity. CONCLUSION: OD is a common presentation of COVID-19 and is more prevalent in mild cases of infection.
format Online
Article
Text
id pubmed-9703475
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-97034752022-11-29 Incidence of Olfactory Dysfunction in Patients with COVID-19 in a Tertiary Hospital in Saudi Arabia Alfallaj, Rayan AlSkait, Ghada Alamari, Nouf Alfawzan, Lama Abualgasem, Mohammed Alotaibi, Naif H. Sumaily, Ibrahim Alarifi, Ibrahim Alsaleh, Saad Allergy Rhinol (Providence) Original Research Article BACKGROUND: Coronavirus disease (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2, a novel virus that emerged in China in December 2019. In many cases of COVID-19, olfactory dysfunction (OD) is the only symptom. OBJECTIVES: This study aimed to examine the incidence of OD in patients with COVID-19 and identify an association between OD and COVID-19-related morbidity and admission. DESIGN: This was a cross-sectional study. METHODS: Real-time reverse transcription polymerase chain reaction-confirmed cases of COVID-19 from the Security Forces Hospital electronic registry from June 2020 to September 2020 were included in our study. Data on medical background, severity of the disease, and other related factors were collected through phone calls and electronic healthcare systems and analyzed to investigate OD in the participants. RESULTS: Of the participants, 68% had OD, with a mean recovery time of 18 days and a mean follow-up time of 129 days (76-211 days). OD was negatively correlated with admission and morbidity. CONCLUSION: OD is a common presentation of COVID-19 and is more prevalent in mild cases of infection. SAGE Publications 2022-11-25 /pmc/articles/PMC9703475/ /pubmed/36452479 http://dx.doi.org/10.1177/21526575221140809 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research Article
Alfallaj, Rayan
AlSkait, Ghada
Alamari, Nouf
Alfawzan, Lama
Abualgasem, Mohammed
Alotaibi, Naif H.
Sumaily, Ibrahim
Alarifi, Ibrahim
Alsaleh, Saad
Incidence of Olfactory Dysfunction in Patients with COVID-19 in a Tertiary Hospital in Saudi Arabia
title Incidence of Olfactory Dysfunction in Patients with COVID-19 in a Tertiary Hospital in Saudi Arabia
title_full Incidence of Olfactory Dysfunction in Patients with COVID-19 in a Tertiary Hospital in Saudi Arabia
title_fullStr Incidence of Olfactory Dysfunction in Patients with COVID-19 in a Tertiary Hospital in Saudi Arabia
title_full_unstemmed Incidence of Olfactory Dysfunction in Patients with COVID-19 in a Tertiary Hospital in Saudi Arabia
title_short Incidence of Olfactory Dysfunction in Patients with COVID-19 in a Tertiary Hospital in Saudi Arabia
title_sort incidence of olfactory dysfunction in patients with covid-19 in a tertiary hospital in saudi arabia
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703475/
https://www.ncbi.nlm.nih.gov/pubmed/36452479
http://dx.doi.org/10.1177/21526575221140809
work_keys_str_mv AT alfallajrayan incidenceofolfactorydysfunctioninpatientswithcovid19inatertiaryhospitalinsaudiarabia
AT alskaitghada incidenceofolfactorydysfunctioninpatientswithcovid19inatertiaryhospitalinsaudiarabia
AT alamarinouf incidenceofolfactorydysfunctioninpatientswithcovid19inatertiaryhospitalinsaudiarabia
AT alfawzanlama incidenceofolfactorydysfunctioninpatientswithcovid19inatertiaryhospitalinsaudiarabia
AT abualgasemmohammed incidenceofolfactorydysfunctioninpatientswithcovid19inatertiaryhospitalinsaudiarabia
AT alotaibinaifh incidenceofolfactorydysfunctioninpatientswithcovid19inatertiaryhospitalinsaudiarabia
AT sumailyibrahim incidenceofolfactorydysfunctioninpatientswithcovid19inatertiaryhospitalinsaudiarabia
AT alarifiibrahim incidenceofolfactorydysfunctioninpatientswithcovid19inatertiaryhospitalinsaudiarabia
AT alsalehsaad incidenceofolfactorydysfunctioninpatientswithcovid19inatertiaryhospitalinsaudiarabia